Piramal Pharma Limited said, "FY25 so far has been a steady year for the Company with revenue growth of 14% and EBITDA growing at 20%. Our CDMO business continues to deliver robust performance ...

Piramal Pharma Ltd said, on Wednesday, January 22, that Piramal Critical Care (PCC), the US division, is launching Chlorpromazine Hydrochloride for Injection, USP in two vial sizes: 25 mg/1 mL and ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Piramal Pharma Ltd share price was down by -7.81% from the previous closing price of ₹200.56. Who are peers of Piramal Pharma Ltd? The peers of Piramal Pharma Ltd are Sun Pharmaceuticals ...

betting all on the pharma industry. Ajay Piramal’s sharp business acumen helped him transform the Piramal Group into a multinational conglomerate with businesses ranging from pharmaceuticals ...

Piramal Pharma Ltd. announced a net profit of ₹3.7 crore in Q3 FY25, against ₹10.1 crore in the corresponding period in FY24, after decreasing 63.4% YoY. Operating revenues of ₹2,204.2 crore ...

Q3 Earnings, Results 2025: Companies like TVS Motor, Hindustan Zinc, Hyundai Motor, GMR Airports, Bajaj Auto, Cipla, Piramal Pharma, are releasing their Q3 numbers today. (Image: Freepik ...

Mumbai: Piramal Enterprises posted muted profit after tax in Q3 FY25 as strong loan growth was partially offset by higher provisions due to asset quality woes. The non-banking financial company ...

Royalty Pharma (RPRX) announced that it has entered into an agreement with Biogen (BIIB) to provide research and development funding of up to $250M for litifilimab, a first-in-class ...

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the ...

OKYO Pharma (OKYO) announces that its lead asset, OK-101, has been officially assigned the United States Adopted Name, USAN, “urcosimod”. Gary Jacob, Ph.D., Chief Executive Officer of Okyo Pha ...